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Summary
Title:  “The impact of changes in neonatal intensive care practices on short-term outcomes of 
premature infants”
Author: Anna Mara Hrgetić Vitols 
Objective:  To assess the changes in neonatal care practices at the NICU-UHC Zagreb and their 
impact on short-term morbidity of a cohort of premature infants. A comparison between two epochs 
was performed, the periods before and after changes in respiratory support, healthcare professionals' 
attitudes and practices in supporting and promoting the breastfeeding, and laboratory phlebotomy 
reduction was introduced. Methods: We performed a retrospective study to investigate short-term 
morbidity of infants born at GA ≤32 weeks and/or BW ≤1500 g and transferred to UHC Zagreb 
from local Zagreb hospitals or remote areas in Croatia in the ﬁrst week of life in the years 2013 and 
2017. Continuous data was represented as mean ± SD, or median (minimum-maximum) values for 
continuous  variables,  and  frequency  percentages  for  categorical  variables.  Characteristics  were 
compared between groups using the 2- sample t-test, Chi square test, or Fisher’s exact test. In all 
cases 2-tailed P values <0.05 were considered statistically signiﬁcant. Results: The use of nCPAP as 
primary respiratory support increased from 25% to 72% (P<0.001) and surfactant use decreased 
from 69% to 33% (P=0.002) between the two time periods. The overall incidence of comorbidities 
was lower in 2017; rate of severe BPD (3 v. 42%, P<0.001), severe ROP (0% v. 14%, P=0.025), 
IVH ≥ 3 (11% v. 33%, P=0.023). The median duration of invasive MV was reduced from 31 days in 
2013 to 6 days in 2017 (P<0.001),  as well  as LOS from 74 days in 2013 to 57 days in 2017 
(P=0.001).  Amount  of  phlebotomy  blood  loss  and  total  number  of  PRBC  transfusions  were 
markedly reduced (from 1128 ml to 564 ml; P=0.004, and form 92 to 36; P=0.009, respectively). 
Incidence of surgical NEC, time to reach full enteral feed, and breastfeeding on discharge remained 
unchanged. Conclusion: Changes in care protocols at the hospital since 2013 have improved the 
outcome of premature neonates. There was a marked improvement in most of the morbidity of very 
low birth weight infants over time, most likely due to provision of nCPAP as primary respiratory 
support.  Usage of nCPAP as primary ventilation support and better policies on blood diagnostic 
procedures have lowered the incidence of comorbidities and decreased hospital stays.  
Key  words:  very  low  birth  weight  infants,  respiratory  support,  red  blood  cell  transfusion, 
bronchopulmonary dysplasia, intraventricular hemorrhage, retinopathy of prematurity  
Sažetak
Naslov: “Utjecaj promjene prakse intenzivnog liječenja na kratkoročne ishode nedonoščadi”
Autor: Anna Mara Hrgetić Vitols 
Cilj: Ispitati utjecaj promjene prakse intenzivnog liječenja u Zavodu za neonatologiju i neonatalnu 
intenzivnu  medicinu  KBC-a  Zagreb  na  kratkoročni  morbiditet  (do  otpusta  iz  bolnice)  kohorte 
nedonoščadi.  Usporedili  smo  ishode  nedonoščadi  u  periodu  prije  i  poslije  promjene  načina 
provođenja respiratorne potpore, stavova zdravstvenih radnika i prakse u podupiranju i promicanju 
dojenja  te  smanjenja  jatrogenog  gubitka  krvi.  Metode:  provedena  je  retrospektivna  analiza 
kratkoročnih ishoda nedonoščadi GD ≤32 tjedana i/ili RM ≤1500 g koja su premještena u KBC 
Zagreb  iz  lokalnih  zagrebačkih  bolnica  ili  udaljenih  područja  Hrvatske  u  prvom tjednu  života 
tijekom 2013. i 2017. god. Kontinuirane varijable prikazane su kao aritmetička sredina i standardna 
devijacija  ili  medijan  (najmanja-najveća  vrijednost),  a  kategorijske  varijable  kao  postotak.  Za 
usporedbu karakteristika bolesnika u dva perioda korišten je t-test na temelju dvaju uzoraka, Χ2-test 
a  po  potrebi  i  Fisherov  egzaktni  test.  U  svim slučajevima  P  vrijednosti  <0.05  smatrale  su  se 
statistički značajnima. Rezultati: Primjena nCPAP-a kao primarne respiratorne potpore porasla je s 
25% tijekom 2013.  god.  na  72% u  2017.  god.  (P<0.001)  uz  istodobno  smanjenje  supstitucije 
surfaktanta s 69% na 33% (P=0.002) . Incidencija komorbiditeta je bila manja u 2017. god. nego u 
2013. god.; stopa teških oblika BPD-a (3 v. 42%, P<0.001), teškog ROP-a (0% v. 14%, P=0.025), 
IVH ≥ 3 (11% v. 33%, P=0.023). Trajanje mehaničke ventilacije je skraćeno s 31 dan u 2013. god. 
na  6  dana  u  2017.  god.  (P<0.001),  kao i  duljina  hospitalizacije  (sa  74  na  57 dana;  P=0.001). 
Značajno je smanjena i  količina gubitaka krvi zbog laboratorijskog uzorkovanja (od 1128 ml u 
2013. god. na 564 ml u 2017. god.; P=0.004) te ukupan broj primijenjenih transfuzija koncentrata 
eritrocita (s 92 na 36; P=0.009). Incidencija NEK-a koji je zahtijevao kiruršku intervenciju, vrijeme 
do uspostave potpunog enteralnog unosa i učestalost dojenja se nisu značajno mijenjali. Zaključak: 
Promjene  prakse  poboljšale  su  ishode  liječene  nedonoščadi  tijekom  vremena,  što  se  ogleda  u 
značajno manjem pobolijevanju u gotovo svim morbiditetnim kategorijama. Primjena nCPAP-a kao 
primarne  respiratorne  potpore  i  bolja  kontrola  gubitaka  krvi  zbog  laboratorijskog  uzorkovanja 
smanjile su incidenciju komorbiditeta i skratile vrijeme liječenja.
Ključne  riječi:  nedonoščad  vrlo  male  rodne  mase,  respiratorna  potpora,  transfuzija  eritrocita, 
bronhopulmonalna displazija, intraventrikularno krvarenje, retinopatija nedonoščadi.  
1. Preface
Infants born very preterm (<32 weeks’ 
gestation)  and  very  low  birth  weight  (birth 
weight  <1500 g)  are  at  an  increased  risk  of 
mortality and multiple morbidities (1). In high-
income  countries,  complications  resulting 
from  preterm  birth  are  the  leading  cause  of 
mortality  in  children  younger  than  5  (2). 
Globally, over a million of those prematurely 
born will die, either as a direct result of their 
prematurity  or  because  preterm  birth  places 
them  at  higher  risk  of  developing  severe 
complications like intracranial haemorrhage or 
sepsis (3). Many of those surviving will face 
long-term  disability  throughout  their  lives 
caused  by  complications  of  premature  birth 
such as bronchopulmonary dysplasia, learning 
difﬁculties and cerebral palsy (3).
Since  mortality  and  the  degree  of 
disabilities can be decreased, practices in the 
neonatology  ﬁeld  are  always  advancing  and 
improving.  From  prenatal  administration  of 
steroids  to  incubators  to  maintain  body 
temperature,  neonatologists are always trying 
to develop new ways to prevent comorbidities 
that could develop in a premature newborn and 
improve  life  quality,  a  trend  that  represents 
itself  with  increasing  survival  rates  of 
premature newborns (4–6).  
In  this  scientiﬁc  paper  I  will  analyse 
these  changes  and  advancements  in  the 
Neonatal  intensive  care  unit  (NICU)  at 
University Hospital Centre Zagreb and discuss 
their  impact  on  the  outcome  of  prematurely 
born infants, with the aim to show if they have 
improved the outcome, not only by decreasing 
comorbidities  but  also  by  shortening  the 
patient’s stay at the NICU.  
1.1. The premature infant 
A  normal  pregnancy  usually  lasts 
around  40  weeks.  This  period,  however,  is 
sometimes  shortened  due  complications  that 
put the life of the fetus, the mother, or both of 
them at risk. If an infant is born before the 37th 
gestational  week,  they  are  considered  a 
premature  neonate.  The  degree  of  their 
prematurity  depends  on  their  gestational  age 
(GA),  which  can  be  calculated  from  the 
mother’s ﬁrst day of their last menstruation, or 
with  the  help  of  ultrasound  imaging  (7,8). 
Depending on the GA, they can be classiﬁed 
as  extremely  preterm  (born  earlier  than  28 
weeks), very preterm (born after 28 weeks but 
before 32 weeks) and late preterm (born after 
32 weeks but before 37 weeks) (3,7). 
Prematurity can also be deﬁned by the 
infant’s birth weight (BW), which may classify 
them as low birth weight (LBW) if their BW is 
less  than  2500  g,  very  low  birth  weight 
(VLBW) if their BW is less than 1500 g, and 
extremely  low birth  weight  (ELBW) if  their 
BW is less than 1000 g (7).
Morbidity  and  mortality  depends 
greatly  on  GA  and  BW  and  are  inversely 
proportional  to  them;  the  lower  the  GA and 
BW, the higher the morbidity and mortality are 
(7,9).  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1.2. Short-term complications 
Short-term  complications  are 
comorbidities  that  arise  during  the  neonatal 
period  of  an  premature  infant  and  typically 
occur during their stay at the NICU. They pose 
an increased risk for mortality and contribute 
to the development of lifelong disabilities (10). 
The  most  frequent  short-term  complications 
are mentioned below.  
1.2.1. Bronchopulmonary 
Dysplasia
Bronchopulmonary Dysplasia (BPD) is 
a  chronic  lung disease  characterised by lung 
inﬂammation,  abnormal  lung  growth,  and 
abnormal  development  of  the  alveoli  and 
pulmonary  vasculature  in  premature  infants. 
The  ethology  is  multifactorial,  combining 
several risk factors including lung immaturity, 
prolonged use of assisted ventilation and high 
oxygen concentrations  (oxidative  stress),  and 
inﬂammation (11). Clinically, the disease will 
manifest by chronic dependance on respiratory 
devices,  increased  need  for  oxygen  at  36 
weeks’  postmenstrual  age  (PMA)  and 
radiographic changes of  the lungs (8,12–14). 
The reported incidence of BPD varies broadly, 
but the National Institute of Child Health and 
Human  Development  (NICHD)  Neonatal 
Network reports that BPD is diagnosed at the 
time of discharge from the NICU in 25% to 
35% of VLBW infants; with infants born at 22 
to 26 weeks at higher risk (15). Discrepancy in 
the literature regarding the incidence of BPD 
might  be  related  to  the  deﬁnition  of  the 
disease, the different protocols for the use of 
oxygen at 36 weeks PMA, to variations in the 
use of postnatal  steroids,  and to a plateau in 
survival  that  may  have  been  reached  among 
extremely  preterm  infants.  Although  clear 
diagnostic criteria have yet to be determined, 
BPD  is  currently  deﬁned  as  the  oxygen 
dependency  for  longer  than  28  days  with 
further assessment of the severity based on the 
oxygen  concentration  and  degree  of  support 
needed at 36 weeks PMA or discharge home, 
whichever comes ﬁrst (Table 1) (16). 
Diminishing  the  time  on  mechanical 
ventilation  (MV)  and  early  introduction  of 
nasal  continuous  positive  airway  pressure 
(nCPAP)  has  decreased  the  severity  of  BPD 
and increased survival.  However,  it  is  still  a 
major comorbidity in premature infants since it 
increases  the  likelihood  of  long-term 
impairment of pulmonary function, persisting 
into  adolescence  and  early  adulthood 
(12,15,17,18).  Furthermore,  BPD  is  an 
independent  risk  factor  for  adverse 
neurodevelopmental  outcome.  Premature 
infants  with  BPD  have  lower  head 
circumferences,  moderate  to  severe  cerebral 
paralysis, and reduced cognitive and language 
scores compared to those without BPD (19).
 
Table  1.  Deﬁnition  of  Bronchopulmonary 
Dysplasia  from  the  NICHD  Workshop  on 
BPD
Gesta
tional 
Age
<32 weeks ≥32 weeks
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Abbreviations:  BPD,  Bronchopulmonary  dysplasia; 
nCPAP, nasal continuous positive airway pressure; PPV, 
positive pressure ventilation; PMA, postmenstrual age.
1.2.2. Intraventricular 
Hemorrhage 
Intraventricular  hemorrhage  (IVH)  is 
one of the common serious complications of 
very preterm birth and an important cause of 
brain  injury  and  subsequent 
neurodevelopmental impairment (8,20). In the 
Vermont-Oxford  Network,  6.2%  of  infants 
with birth weights 500 to 1500 g had a serious 
(grade III of IV) IVH in 2000 to 2001 and in 
2008 to 2009 (21).
The bleeding almost always starts from 
the  fragile  vessels  located  in  the  infant’s 
germinal  matrix.  Hemorrhage  may  be 
restricted  to  the  subependymal  germinal 
matrix,  but  large  hemorrhages  are  often 
followed  by  progressive  ventricular 
enlargement and/or parenchymal hemorrhagic 
infarction in the adjacent periventricular white 
matter through the mechanism of obstruction 
to the terminal vein. The amount of blood lost 
may be large enough to result in hypotension, 
hypovolemia, and death (14,17,20). 
According to Papile, IVH is classiﬁed 
by  severity  into  four  grades  (Table  2)  (17). 
IVH can be assessed with imaging technology 
like US and MRI (8,14,20). 
Table 2. Papile Grading of Intraventricular 
Hemorrhage
Time 
point 
of 
assess
ment
36 weeks’ PMA 
or discharge to 
home, 
whichever 
comes ﬁrst
>28 days, but 
<56 days’ 
postnatal age or 
discharge home, 
whichever comes 
ﬁrst
Treatment with oxygen >21% for 
at least 28 days PLUS
Mild 
BPD
Breathing room 
air at 36 weeks’ 
PMA or 
discharge, 
whichever 
comes ﬁrst
Breathing room 
air by 56 days’ 
postnatal age or 
discharge, 
whichever comes 
ﬁrst
Mode
rate 
BPD
Need for <30% 
oxygen at 36 
weeks’ PMA or 
discharge, 
whichever 
comes ﬁrst
Need for <30% 
oxygen at 56 
days’ postnatal 
age or discharge, 
whichever comes 
ﬁrst
Sever
e 
BPD
Need for ≥30% 
oxygen and/or 
PPV/nCPAP at 
36 weeks’ PMA 
or discharge, 
whichever 
comes ﬁrst
Need for ≥30% 
oxygen and/or 
PPV/nCPAP at 
56 days’ 
postnatal age or 
discharge, 
whichever comes 
ﬁrst
Grade Description
Grade 
I
Hemorrhage conﬁned to the 
subependymal germinal matrix in 
the caudothalamic groove
Grade 
II
Hemorrhage in germinal matrix 
and a small amount within 
ventricular lumen, with the clot 
occupying less than 50% of the 
ventricular lumen and not 
distending the ventricular system
Grade 
III
Germinal matrix hemorrhage with 
a large amount of clot (>50% of 
ventricular lumen) distending the 
ventricular system
Grade 
IV
Germinal matrix and 
intraventricular hemorrhage in 
apparent continuity with 
hemorrhage into the 
periventricular white matter
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Preventive methods have been studied. 
Antenatal  corticosteroids  before  preterm 
delivery  have  shown  a  very  consistent 
reduction  in  IVH,  including  severe  IVH  in 
many  randomized  trials  (14,20).  Other 
preventive  measures  include  delayed  cord 
clamping, allowing transfusion of blood from 
the  placenta  (22),  and  avoiding  postnatal 
swings in intracranial pressure (14). Antenatal 
vitamin  K  has  been  investigated  in  seven 
randomized clinical trials, but a meta-analysis 
did not show a signiﬁcant beneﬁt (23).
Treatment  is  mostly  supportive  with 
the aim to maintain adequate blood perfusion 
(14,24)  and  current  goal  is  early  diagnosis 
through  regular  ultrasound  screenings 
followed by immediate treatment (20).  
In general, grade I and II hemorrhages 
carry  good  prognosis,  but  serious 
complications are associated with grade III and 
IV,  respectively  (17).  Bleeding  into  the 
parenchyma can lead to the formation of cystic 
lesions  called  cystic  periventricular 
leukomalacia  (cPVL),  which  result  in  long-
term disabilities, including neurologic deﬁcits 
(14,25).  
1.2.3. Necrotizing 
Enterocolitis 
Necrotizing  enterocolitis  (NEC)  is  a 
devastating gastrointestinal disease that affects 
predominantly  premature  newborns.  The 
prevalence of this disease is about 7% among 
infants  born at  less  than 32 weeks'  gestation 
with BW between 500 and 1500 g (26). It is 
characterized  by  ischemic  intestinal  necrosis 
and  is  considered  a  medical  emergency  and 
one  of  the  major  causes  of  mortality  in  the 
NICU. The mortality of NEC is 20% to 30%, 
with the greatest mortality among infants who 
require  surgery  (27).  Little  is  known  of  the 
pathophysiology behind NEC, other than it is 
multifactorial.  However,  gut  immaturity, 
aggressive  initiation  of  enteral  feeding 
(formula),  decreased  blood  ﬂow,  and 
infections  have  all  been  identiﬁed  as  key 
players (8,17,28). 
Feeding  intolerance  and  abdominal 
distention  are  typical  signs  of  NEC.  In 
addition,  clinical  signs  also  include 
temperature instability, vomiting, bloody stool, 
diarrhea,  and  abdominal  tenderness.  Within 
hours  after  onset  of  initial  symptoms,  it  can 
progress rapidly to necrosis of the intestines, 
intestinal perforation, peritonitis, septic shock, 
and death. Time of presentation depends on the 
degree  of  prematurity  of  the  neonate, 
occurring  sooner  in  less  premature  patients 
(8,17,28,29).
Diagnosis  is  made  based  on  clinical 
signs  and  conﬁrmed  by  plain  abdominal 
radiograph, which illustrates air in the bowel. 
Furthermore, organisms may be cultured from 
blood  samples  in  cases  of  septicemia 
(17,28,29).  Treatments  include  stomach 
decompression  by  nasogastric  suction,  ﬂuid 
replacement  and  switching  from  enteral 
feeding to parenteral nutrition until resolution 
of symptoms. The use of empirical antibiotics 
is  also  recommended  to  limit  progression. 
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Finally,  surgery  is  the  treatment  for  infants 
with intestinal perforation or gangrene (17,30).
Many approaches have been proposed 
for the prevention of NEC. Gradual increase of 
trophic  feeding  (nonaggressive  enteral 
feeding)  as  well  as  feeding  maternal  breast 
milk (31) have been proven to offer protection. 
Although  several  trials  suggest  that 
administration of probiotics may provide some 
degree  of  protection  and  decrease  the 
incidence  of  NEC (17),  it  would  be  wise  to 
exert  caution  in  their  use  in  preterm infants 
because  probiotics  have  not  been  shown  to 
decrease  NEC-related  mortality  deﬁnitively 
and  may  increase  the  incidence  of  sepsis  in 
infants with BW less than 750 g (32).
1.2.4. Retinopathy of 
Prematurity
Retinopathy  of  prematurity  (ROP) 
refers  to  changes  on  the  retina  that  can  be 
found in the immature retina of preterm infants 
and it is strongly related to blindness, myopia 
and strabismus (33–35).
In the past,  it  was believed that  ROP 
was  merely  associated  with  hyperoxia. 
Nowadays, it is thought that multiple causes, 
including  assisted  ventilation,  intracranial 
hemorrhage  (ICH),  hyperglycemia,  vitamin 
deﬁciencies among others, are involved in the 
pathogenesis since any of these processes can 
injure  the  developing  vessels  and  cause  an 
abnormal retinal vascularization (8,14,17,34). 
Diagnosis  and  grading  are  done  by 
looking  directly  at  the  retina  with  a  lens  or 
indirectly with an ophthalmoscope. Grading is 
done  on  stages  that  go  from  I  to  V  and  it 
depends  on  the  development  of  vessels  on 
speciﬁc  zones  and  the  damage  this  growth 
causes to the retina (8,14,29,36). 
Prevention is  encouraged by avoiding 
oscillations  of  blood  pressure  and  oxygen 
saturation (14). Breast milk is considered to be 
a protective factor against ROP (35). Routine 
screening  is  the  key  for  early  detection  and 
treatment  and  follow-up  with  an 
ophthalmologist  is  recommended  until  the 
abnormalities  resolve.  Possible  treatment 
options  available  for  advanced  stages  of  the 
disease  are  laser  photocoagulation,  which  is 
the  prefered treatment,  cryotherapy and anti-
vascular endothelial growth factor (8,14,33). 
1.3. Common practices in the 
NICU
Because preterm neonates are prone to 
numerous  pathologies,  some  of  them 
mentioned  above,  they  need  to  receive 
different care protocols during their stay at the 
NICU. These practices are discussed below. 
1.3.1. Phlebotomy  and 
Blood Transfusion. 
Phlebotomy is necessary to assess the 
neonate’s development and wellbeing through 
different  laboratory  values.  However,  blood 
loss  due  to  blood  sampling  is  the  most 
common cause of iatrogenic anemia and one 
of  the  most  common  causes  of  anemia  of 
prematurity. Therefore, every instance of blood 
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drawing should be recorded and tighter control 
on  blood  sampling  and  testing  should  be 
imposed (8,14,37). 
To  treat  anemia,  newborns  receive 
blood  transfusions.  However,  recent 
publications  show that  transfusions  might  be 
more  harmful  than  beneﬁcial  since  frequent 
blood transfusions appear to increase the risk 
for comorbidities like BPD and NEC (38–40).
1.3.2. Respiratory Support
Respiratory  care  is  considered one of 
the  interventions  that  greatly  improved  the 
survival  rate  of  premature  neonates. 
Mechanical  ventilation  (MV)  was  ﬁrst 
introduced  to  prevent  neonates  to  go  into 
cardiorespiratory  failure.  However,  with  the 
introduction  of  MV,  pathologies  like  BPD 
started  to  appear.  Nasal  CPAP (nCPAP)  was 
introduced as a non-invasive alternative to MV 
and  allowed  for  continuous  spontaneous 
respiration  with  a  diminished  need  for 
intubation. Later, several trials proved that the 
use of nCPAP prophylactically or as a mode of 
primary  ventilation  lowered  the  need  for 
intubation  and  decreased  the  incidence  of 
BPD, even without  treatment  with  surfactant 
(18,41–43).
2. Hypothesis
Preterm  infants  who  are  exposed  to 
newer medical protocols will have less severe 
short-term comorbidities and better outcomes 
than  preterm  infants  which  were  treated 
according to older protocols.  
3. Objective 
The aim of the study was to evaluate 
the  impact  of  changes  in  neonatal  intensive 
care  practices  on  short  term  outcomes  and 
length  of  hospital  stay  of  VLBW  infants 
admitted  to  the  NICU  of  the  University 
Hospital Centre (UHC) Zagreb in 2013, and to 
compare that data with data from 2017 at the 
same Unit.  
4. Material and Methods
Ethical approval
The  data  was  collected  without 
identiﬁcation.  Due to  the  study design (non-
interventional, retrospective cohort study) the 
written consent was waived.
Inclusion and exclusion criteria
This study retrospectively reviewed the 
medical records of all premature infants born 
at  a  PMA ≤32 weeks and/or a BW ≤1500 g 
who were subsequently admitted to the NICU 
of a tertiary medical center. The UHC Zagreb 
lacks  a  maternity  ward,  thus  all  neonates  in 
this study are outborns, either transferred from 
local  Zagreb  hospitals  or  remote  areas  in 
Croatia. 
We compared the outcomes of VLBW 
infants between 2 epochs, before and after the 
changes  in  neonatal  intensive  care  practices. 
The  ﬁrst  epoch  encompassed  the  patients 
admitted  between  January  1,  2013  and 
December  31,  2013  and  the  second  epoch 
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between  January  1,  2017  and  December  31, 
2017.
Newborns  with  major  congenital  and 
chromosomal anomalies, hydrops fetalis, those 
admitted  moribund or after the age of 7 days, 
newborns who died in the ﬁrst week of life, as 
well  as  those  transferred  to  other  NICU’s 
before the age of 7 days were excluded. 
Data collection
Patient  variables  that  were  abstracted 
included  demographic  information  (date  of 
birth,  sex,  place  of  birth),  birth  information 
(delivery  hospital,  antenatal  steroids,  GA 
assessed by menstrual age, BW, Apgar scores), 
physiological  variables  obtained early  during 
hospitalization  (SNAP-II,  SNAPPE-II,  body 
temperature  on  admission),  exogenous 
surfactant  administration,  initial  respiratory 
support  in  the  NICU,  and  duration  of 
respiratory  support.  The  amount  of 
phlebotomy blood loss, the number of infants 
transfused and the number of transfusions per 
infant were retrieved for the period from the 
day of admission to the day of discharge from 
hospital. All infants were divided into 2 groups 
according to type of feeding they received at 
discharge: exclusively breast milk and mixed 
feeding  (Group  1)  or  exclusively  artiﬁcial 
formula (Group 2). Frequencies of each group 
were calculated. Intrauterine growth restriction 
(IUGR) was deﬁned as a birth weight below 
10th percentile for GA on Fenton’s fetal growth 
charts.  The  percentiles  were  calculated  on 
Ped(z),  an  online  pediatric  calculator  using 
Fenton data (44). The SNAP-II and SNAPPE-
II  scores  were  obtained  with  the  help  of  an 
online  calculator  developed  by  the  French 
Society of Anesthesia and Resuscitation (45). 
Patient care protocols
In UHC-NICU, routine MV mode was 
patient-triggered  modality  using  a  Babylog 
8000+ (Drager,  Lubeck,  Germany)  PSV+VG 
(pressure  support  ventilation  +  volume 
guarantee)  and  non  invasive  ventilation  was 
performed  with  Infant  Flow  nCPAP  (Care 
Fusion, USA) with nasal prongs or mask with 
an initial  mean airway pressure value of  5-7 
cmH2O in both epochs. 
Epoch I 
Standard  approach  to  neonates  with 
RDS  was  tracheal  intubation  immediately 
upon admission with surfactant administration 
and ongoing (prolonged) MV. Neonates were 
extubated  and  switched  to  nCPAP-Biphasic 
mode  when  complete  lung  recovery  was 
achieved  according  to  ventilatory  parameters 
(PIP<15  cmH2O,  FiO2<30%  with  SpO2 
90-95%),  and  blood  gas  analysis  (permitting 
hypercapnia  ≤65  mmHg).  In  neonates 
intubated prior to admission in the NICU, MV 
was  continued  until  the  above-mentioned 
extubation criteria were met.  
Laboratory  tests  were  ordered  as  a 
matter of routine and there was no monitoring 
of the accumulative blood loss volume. Infants 
were  fed  mainly  with  bovine  milk-based 
preterm formula.
Epoch II
Not intubated neonates with RDS were 
placed on nCPAP-Biphasic mode immediately 
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upon arrival. If the infant’s FiO2  requirement 
increased to >60% on non-invasive respiratory 
support to maintain an saturation of peripheral 
oxygen  (SpO2)  at  or  above  88%,  with  signs 
that respiratory support with a ventilator will 
be  needed  (pCO2  >65  mmHg)  or 
hemodynamic  instability  deﬁned  as  a  blood 
pressure that was low for GA, poor perfusion, 
or  both;  early  administration  of  surfactant 
followed  by  rapid  extubation  to  nCPAP was 
preferable to prolonged ventilation.  Neonates 
who were intubated prior to admission in the 
NICU,  were  switched  to  nCPAP as  early  as 
possible,  depending  on  their  respiratory 
condition and criteria mentioned above (pCO2 
<65 mmHg with a pH >7,2; SpO2 >88% with 
an  FiO2  <50%,  MAP  <15  cm  H2O, 
hemodynamic  stability).  Criteria  for 
reintubation were the same as those for initial 
intubation.  
In  order  to  prevent  laboratory  blood 
loss,  we  have  implemented  a  policy  of 
conservative  blood  management.  Laboratory 
diagnostic tests were decided on a day-to-day 
basis rather than scheduled automatically, and 
careful  monitoring of the cumulative volume 
of blood samples acquired from each patient 
was done.  
In epoch II, process of family-centered 
care  in  NICU  was  started.  Unrestricted 
parental  presence  in  the  NICU,  parental 
involvement  in  infant  caregiving, 
breastfeeding,  and  kangaroo  care  were 
promoted to enhance mother-infant bonding.
Outcomes
The main outcomes were the degree of 
severe  morbidity  among  infants  discharged 
alive.  Severe  neonatal  morbidity  comprised 
severe grades of NEC (assessed by surgery or 
peritoneal  drainage),  ROP  (laser  treatment, 
intravitreal bevacizumab), IVH (grades III or 
IV; classiﬁed according to Papile et al. (46)) or 
cPVL,  and  BPD  (as  deﬁned  by  Jobe  and 
Bancalari  (16)).  The  secondary  measured 
outcome was the LOS, and transfusion rates. 
Statistical analysis
Data  are  presented  using  mean  ± 
standard deviation (SD) or median (minimum-
maximum)  values  for  continuous  variables, 
and  frequency  percentages  for  categorical 
variables.  Characteristics  were  compared 
between groups using the 2- sample t-test, Chi 
square test, or Fisher’s exact test. In all cases 
2-tailed  P  values  <0.05  were  considered 
statistically signiﬁcant.  
5. Results 
The basic data and clinical information 
of 120 VLBW infants admitted to a NICU in 
2013  and  2017  were  extracted  from  the 
hospital’s database: 63 and 57 patients in 2013 
and  2017,  respectively.  Forty  eight  patients 
were excluded (27 and 21 in ﬁrst and second 
epoch, respectively) because they were either 
admitted after the 7th  day of life (n=23), had 
fetal  hydrops (n=1),  congenital  malformation 
or  chromosomal  anomalies  (n=5),  were 
transferred from NICU to other facility before 
the  age of  7  days  (n=2),  or  died in  the  ﬁrst 
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30.7  days,  compared  to  7  infants  (20%, 
P<0.001) supported for a median of 5.6 days 
(P<0.001)  in  2017.  In  2013,  only  25%   of 
infants  were  treated  with  nCPAP as  primary 
respiratory support or in an attempt to extubate 
and switch to nCPAP upon arrival,  compared 
with 72% in 2017. These results are illustrated 
in Figure 2, where the difference on both MV 
and oxygen therapy can be easily compared.
Table 4 describes the rates of short-term 
morbidities  in  the  two  cohorts.  All 
complications  occurred  less  frequently  in  the 
second  epoch.  The  incidence  of  BPD  was 
signiﬁcantly lower in 2017 than in 2013 (44 v. 
78%,  P<0.001),  especially  in  the  severe 
spectrum  of  the  disease  (3  v.  42%).  The 
incidence of severe ROP was also reduced in 
2017  compared  to  the  2013  cohort  (0%  v. 
14%). No infant was treated for ROP in 2017. 
In 2013 ﬁve infants, who were all BW <1100 
g,  were  treated  for  ROP  using  laser  or 
intravitreal  bevacizumab.  In  2017,  there  was 
also a signiﬁcant reduction in the proportion of 
IVH grades III and IV (11% v. 33%). 
The  overall  median  of  LOS  for 
surviving infants was reduced from 74.4 days 
(25.1-358.4  days)  in  2013  to  56.5  days 
(13.5-110.2  days)  in  2017.  There  were  no 
differences  in  median  PMA  on  hospital 
discharge between the two cohorts (40 v. 37.7 
in 2013 and 2017, respectively).   
Table 4. Demographics and clinical dataa 
1st Epoch - 2013 
(n=36)
2nd Epoch - 2017 
(n=36) P
Male sex 20 (56) 20 (56) 1.000
Gestational age, wk 28 (2.4) 29.3 (1.9) 0,844
Birth weight, g 1,085 (560-1,860) 1,295 (780-1,840) 0,072
Intrauterine growth restriction 4 (11) 4 (11) 1.000
Birth weight <1000 g 8 (22) 4 (11) 0,206
Antenatal steroids NA 23 (64) -
Apgar score 
1st min
   ≤6
   ≥7
5th min
  ≤6
  ≥7
(n=35)
23 (66)
12 (34)
(n=34)
13 (38)
21 (62)
(n=35)
19 (54)
16 (46)
(n=35)
13 (37)
22 (63)
0.329
0.925
Age at admission, h 2.1 (0.8-143.4) 3 (0.5-130) 0,818
Respiratory support
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Abbreviations: DOL, day of life; HFNC, high-ﬂow nasal cannula; IVH, intraventricular hemorrhage; NA, non 
available; NEC, necrotizing enterocolitis; PMA, postmenstrual age; ROP, retinopathy of prematurity.
a Values are number of patients (%), mean (standard deviation), or median (minimum-maximum).
1 2 patients discharged on supplemental oxygen; 21 ventriculoperitoneal shunt.
SNAPPE-II
(n=30)
32 (0-133) 23 (0-84) 0,068
Primary mode of ventilation
   invasive mechanical ventilation
   nCPAP/extubation to nCPAP
   none/HFNC
26 (72)
9 (25)
1 (3)
7 (20)
26 (72)
3 (8)
<0,001
Primary nCPAP failure 3 (33) 7 (27) 0,787
Total duration of invasive 
mechanical ventilation, d
(n=29)
30.7 (0.5-105)
(n=19)
5.6 (0.1-23)
<0,001
Surfactant administration 25 (69) 12 (33) 0,002
Pneumothorax after admission 0 (0) 3 (8) 0,239
Oxygen, DOL 50 (4-359)1 27 (4-89) 0,004
Length of stay
NICU stay, d 73 (15-235) 54 (14-104) <0,001
Hospital stay, d 74 (25-358) 57 (14-110) 0,001
Discharge to home (from NICU) 21 (58) 22 (61) 0,810
PMA on hospital discharge, wk 40 (34.4-76.7) 37.7 (33.1-46) 0,508
Morbidity
Bronchopulmonary dysplasia
   none
   mild
   moderate
   severe
8 (22)
11 (30)
2 (6)
15 (42)
20 (56)
10 (27)
5 (14)
1 (3)
<0,001
IVH ≥3 12 (33)2 4 (11) 0,023
ROP, laser therapy/intravitreal 
bevacizumab
5 (14) 0 (0) 0,025
Surgical NEC 2 (6) 2 (6) 1.000
Time to full enteral feed, d
(n=33)
36 (12-117)
(n=35)
34 (9-95) 0,330
Feeding on discharge
   breast milk/mixed
   formula
10
26
16
20
0,141
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Figure 2. Duration of mechanical ventilation, oxygen administration and length of stay during 
two time periods  
Figures 3 and 4 show the percentage of 
VLBW infants, grouped by weight, who were 
placed  on  either  MV  or  nCPAP as  primary 
ventilation of mode. A statistically signiﬁcant 
difference was found in the subgroup of infants 
with  BW  <1000  g  (P=0.002)  and  BW 
1000-1500  g  (P=0.006);  in  2013  all  infants 
<1000  g  (n=8)  were  placed  on  MV.  This 
approach  completely  changed  in  2017  as  all 
infants  with  BW  <1000  g  (n=4)  received 
nCPAP  support.  Although  there  were  more 
infants  supported  with  nCPAP  in  the  BW 
>1500 g subgroup in the second epoch, it did 
not reach statistical signiﬁcance (P=0.109).  
Figure 3. Mechanical ventilation by birth 
weight in VLBW infants during two times 
periods
 
Figure 4. nCPAP by birth weight in VLBW 
infants during two times periods
 
Figure  5  compares  the  incidence  and 
severity of BPD in Epoch 1 and 2, showing a 
decrease  between  2013  and  2017. 
Improvements on  lessening  the 
d e g r e e  o f disease  can  also 
seen,  the  most  striking  is  the  change  in  the 
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n=2

Table 5. Demographic and clinical characteristics of the 36 surviving infants in ﬁrst Epoch 
(2013) according to BPD
Abbreviations: DOL, day of life; IVH, intraventricular hemorrhage; NEC, necrotizing enterocolitis; PRBCT, packed red 
blood cell transfusion; ROP, retinopathy of prematurity
a Values are number of patients (%), mean (standard deviation), or median (minimum-maximum).
BPD 
none/mild
(n=19)
BPD
moderate/severe
(n=17)
P
Gestational age, wk 30.1 (25-32.7) 26.7 (24-31) 0,736
Birth weight, g 1,220 (880-1,860) 1,010 (560-1,530) 0,001
Intrauterine growth restriction 2 (11) 2 (12) 0,906
Birth weight <1000 g 1 (5) 7 (41) 0,01
SNAPPE-II
(n=17)
26 (0-95)
(n=13)
57 (13-133) 0,132
Primary mode of ventilation
   Invasive mechanical ventilation
   nCPAP/extubation to nCPAP/  
   None
11 (58)
8 (42)
15 (88)
2 (12)
0,042
Invasive mechanical ventilation, d 5 (0-32) 70 (0.5-105) <0,001
Oxygen, DOL 32 (5-54) (n=14)
91 (43-359)
<0,001
NICU stay, d 62 (15-139) 117 (65-235) <0,001
Hospital stay, d 62 (23-139) 117 (65-358) <0,001
Discharge to home (from NICU) 11 10 0,955
IVH ≥3 3 (16) 9 (53) 0,018
ROP - laser therapy/intravitreal 
bevacizumab
0 (0) 5 (29) 0,016
Surgical NEC 0 (0) 2 (12) 0,216
Time to full enteral feed, day 31 (12-50) (n=14)63 (14-117) <0,001
Feeding on discharge
   breast milk/mixed 
   formula
8 (42)
11 (58)
2 (12)
15 (88)
0,042
PRBCT, n of patients 11 (58) 15 (88) 0,042
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Table  6  compares  phlebotomy  blood 
loss  and  packed  red  blood  cell  transfusion 
(PRBCT) between the two epochs. The amount 
of phlebotomy blood loss was greatly reduced 
from a median of 29 ml (10-97 ml) in 2013 to 
15  ml  (5-58  ml)  in  2017.  The  number  of 
patients who received PRBC are lower in 2017 
(n=19) than in 2013 (n=26). Additionally, the 
number of PRBC per patient (3.5 v. 2) and ml 
of  PRBC  per  patient  (57  v.  35  ml)  also 
decreased in 2017, in comparison to 2013.  
Table 6.  Phlebotomy blood loss and packed red blood cell transfusion
Abbreviation: PRBCT, packed red blood cell transfusion
* missing data for 5 infants (3 of them received multiple PRBC transfusions)  
Table 7 compares infants who received 
and those who did not receive PRBCT in both 
epochs. BW was lower in the group of patients 
who received PRBCT, and this trend could be 
observed in both epoch 1 (1,050 g v. 1,360 g) 
and epoch 2 (1,250 g v. 1,460 g), as illustrated 
in Figure 6. Represented in ﬁgure 7, the groups 
of  patients  that  received  PRBCT  had  larger 
phlebotomy blood loss than patients who did 
not receive PRBCT (36 v. 15 ml and 19 v. 9 ml; 
in 2013 and 2017, respectively). The incidence 
of  BPD  was  higher  in  patients  who  had 
received PRBCT on both 2013 (92% v. 30%) 
and 2017 (68% v. 24%).  
1st Epoch - 2013 
(n=36)
2nd Epoch - 
2017 (n=36) P
Amount of phlebotomy blood loss, ml
   total
   median (min-max)
1128*
29 (10-97)
564
15 (5-58)
0,004
No. of patients who received PRBC 
transfusion
26 (72.2) 19 (52.8) 0,088
PRBCT, n
   total
   per patient, average
   per patient, median (min-max)
n=26
92
3.5
3 (1-9)
n=19
36
2
2 (1-4)
0,009
PRBCT, ml
   
   total
   per patient, average
   per patient, median (min-max)
n=26
2212
85
57 (15-310)
n=19
882
46
35 (10-141)
0,047
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Table 7. Comparison between infants who received and those who did not receive PRBCT in 
two Epochs
Abbreviations: BPD, bronchopulmonary dysplasia; BW, birth weight; GA, gestational age; SNAPPE-II, 
score for neonatal acute physiology with perinatal extension-II
 
Figure 6. Mean PRBCT number by birth weight at the two periods 
1st Epoch - 2013 2nd Epoch - 2017
PRBCT+
(n=26)
PRBCT -
(n=10)
P
PRBCT+
(n=19)
PRBCT -
(n=17)
P
GA, wk
27.7 
(24-32)
31 
(28-32.7)
0,639 29 
(26-31)
30 
(27.9-34)
0,943
BW, g
1,050 
(560-1,740)
1,360 
(1,000-1,860) 0,002
1,250 
(780-1,840)
1,460 
(990-1,760) 0,016
SNAPPE-II
(n=21)
37 
(5-133)
(n=9)
23 
(0-58)
0,074 35 
(5-84)
(n=16)
17
(0-60)
0,012
Phlebotomy 
blood loss, ml
(n=21)
36 
(19-97)
15 
(10-26)
0,006 19 
(8-58)
(n=16)
9 
(4-22)
0,045
BPD, n
(mild, 
moderate, 
severe)
24 (92) 3 (30) <0,001 13 (68) 4 (24) 0,007
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Figure 7. Volume of blood loss and transfusion at two time periods  
8. Discussion
This  study summarized the  short-term 
outcomes of VLBW infants who were admitted 
and treated at  the NICU of the UHC Zagreb 
during the year 2013 and the year 2017. These 
two  years  were  chosen  deliberately  because 
some protocols changed during that period of 
time. The most prominent was the designation 
of nCPAP as the primary method of respiratory 
support.  Other  changes  involved  stricter 
control  on  blood  draws  and  family-centered 
care  practices  such  as  unrestricted  parental 
visits, and family presence and participation in 
care in the NICU. 
Comparison of outcomes before and after the 
introduction of nCPAP as primary method of 
respiratory support 
Between the years 2013 and 2017, the 
NICU  at  the  UHC  Zagreb  switched  their 
primary  mode  of  ventilation  from  MV  to 
nCPAP. This change has notably decreased the 
need of MV and oxygen therapy. 
In  different  published  papers,  the 
prolonged use of MV and oxygen therapy has 
been linked with a  higher  risk of  developing 
different comorbidities when compared to the 
use of nCPAP (42,43,47,48). In our study these 
results  could  be  repeated  since  the  overall 
incidence of BPD decreased from 78% to 44%. 
More  impressively,  severe  BDP  diminished 
from  42%  to  3%  after  the  introduction  of 
nCPAP as ﬁrst choice for respiratory support. 
Our study is also in concordance with 
papers  reporting  that  the  use  of  nCPAP 
diminishes the duration of ventilation (42,43). 
In 2013, the mean duration of ventilation was 
31  days  (0.5-105  days),  which  signiﬁcantly 
dropped to 6 days (0.1-23 days) in 2017. 
A decrease in incidence and severity of 
comorbidities have also been reported with the 
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increased use of  nCPAP (49).  This  trend can 
also  be  observed  in  our  results:  a  decline  in 
incidence of IVH ≥3 (33% v. 11%) and severe 
ROP  (14%  v.  0%)  were  noted  since  the 
replacement  of  MV with  nCPAP as  primary 
method of ventilation.
Importance  of  regulation  of  laboratory 
diagnostics 
The  volume  of  blood  drawn  is 
signiﬁcantly increased by unnecessary testing, 
and without monitoring quantity of blood taken 
it is easy for a neonate to become anemic. In 
fact, Fanaroff et al. (8) stated that a neonate on 
MV therapy might lose over 5 ml of blood per 
day  for  laboratory  diagnostics,  which  is  a 
substantial  amount  for  an  infant  who weighs 
less than 1,500 g. 
Between 2013 and 2017, a strategy of 
conservative  blood  management  was 
implemented at the NICU of the UHC Zagreb. 
Before  the  introduction  of  newer  protocols, 
blood  tests  were  routinely  made  without 
adequate  monitoring.  Now,  the  decision  on 
what  tests  are  necessary  is  made  on  a  daily 
basis rather than scheduled automatically. This 
has resulted in a  decrease in  the phlebotomy 
blood loss from a median of 29 ml (10 - 97 ml) 
in 2013 to 15 ml (5 - 58 ml) in 2017.
Decrease in blood loss has also led to a 
decreased the need for  blood transfusions.  In 
2013,  26  patients  received  transfusions, 
compared  to  only  19  patients  in  2017. 
Furthermore,  the  amount  of  blood  transfused 
also decreased, from an average of 85 ml per 
patient in 2013 to an average of 46 ml in 2017.
Different researchers have claimed that 
blood  transfusions  increase  the  risk  of  BPD 
(38,39)   and  our  analysis  showed  similar 
results.  Out  of  26  patients  who  received 
PRBCT in 2013, 92% (n=24) developed BPD. 
In  contrast,  among  the  patients  who  did  not 
receive  PRBCT  (n=10),  only  3  patients 
developed  BDP  (P  <0.001).  Results  were 
similar in 2017, where out of the 19 patients 
who  received  PRBCT,  68%  (n=13)  were 
diagnosed with BPD, while of the 17 patients 
who  did  not  receive  transfusion,  only  4 
developed BPD (P=0.007). 
Kangaroo care, breastfeeding and 
encouraging parental participation. 
The  new  worldwide  tendency  is  to 
allow parents to spend as much time as they 
want with their newborn while hospitalized in 
the NICU. Parents are allowed touch, talk and 
are encouraged to help with certain basic care 
activities. 
Feeding with breast milk is advocated 
and prefered over the use of formula because it 
offers  passive  immunity,  is  rich  in  nutrients, 
and is easier to digest. Furthermore, it provides 
protection to comorbidities  that  might  appear 
in a preterm newborn such as NEC (50,51). 
Kangaroo  care  is  a  relatively  new 
technique where the neonate is placed on the 
parent’s naked chest. It has shown to regulate 
the  infant’s  body  temperature,  heart  rate  and 
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breathing  pattern.  It  also  reduces  stress  and 
pain and it is easier for breastfeeding  (52,53). 
In 2013, infants were fed mainly with 
bovine milk-based preterm formula and visits 
were  regulated.  Currently,  breast  milk  is 
encouraged, as well as parental involvement in 
infant  caregiving.  In  the  analysis  of  patients 
who developed BPD, it was noted that a group 
of patients who developed BPD were less fed 
with their mother's milk than those who did not 
develop BPD (Table 3, p.16).
And while there is no speciﬁc variable 
that could prove this theory, infants in 2017 did 
had  better  outcome  than  in  2013.  Median 
length  of  stay  for  surviving  infants  was 
reduced  and  complications  occurred  less 
frequently in the second epoch.  
Limitations 
It  is  important  to  note  that  due  to  its 
retrospective nature, our study was limited by 
missing information. This was more evident for 
the  record  from  the  year  2013.  Usage  of 
antenatal  corticosteroids  had  to  be  excluded 
from analysis due to incomplete or inaccurate 
data  from most  ﬁles  dating  from 2013.  This 
variable would have provided a better insight 
in the decrease of comorbidities, like IVH and 
NEC, since studies have proven links between 
the  antenatal  corticosteroids  and  better  short 
term outcomes (54–56). 
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9. Conclusion
When compared, newer protocols have 
improved short-term outcomes in hospitalized 
premature  neonates.  Usage  of  nCPAP,  better 
policies  on  blood  diagnostic  procedures,  and 
family-centred care procedures seems to have 
decreased the incidence and severity of short-
term  comorbidities  and  decreased  the  LOS. 
This  study  supports  the  use  of  nCPAP  as 
primary  ventilation  or  prophylactically  and  a 
strict control on blood tests in order to improve 
the prognosis of VLBW neonates. 
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